Case-Based Learning on Medication Optimization Across Multiple Care Transitions

Abstract

Medication optimization is critical for ensuring patient safety and therapeutic efficacy, particularly during transitions across different care settings. Case-based learning offers a pragmatic approach to educate healthcare professionals about the complexities and best practices of medication management during these transitions. This review synthesizes current evidence, clinical guidelines, and practical strategies for medication optimization, emphasizing risk mitigation, communication, and interprofessional collaboration. Special attention is given to epidemiology, pathophysiology, clinical features, and recent advances relevant to transitions in care, providing a comprehensive resource for clinicians dedicated to improving patient outcomes.

Introduction

Transitions of care, such as hospital admission, discharge, and transfer between various healthcare facilities, are recognized as high-risk periods for medication errors and adverse drug events (ADEs). The complexity of modern pharmacotherapy, coupled with fragmented communication across care settings, underscores the need for robust strategies to optimize medication use. Case-based learning, rooted in real-world clinical scenarios, is increasingly adopted to bridge knowledge gaps and foster clinical reasoning among clinicians. This review examines the evidence base for medication optimization across care transitions and illustrates practical applications through case-based learning methodologies.

Epidemiology / Disease Burden

Medication errors and ADEs during care transitions constitute a significant public health concern. Studies indicate that up to 60% of medication discrepancies occur at hospital admission or discharge, often leading to preventable harm. Elderly patients, those with polypharmacy, and individuals with multimorbidity are particularly vulnerable. The World Health Organization has identified medication safety during transitions as a global patient safety priority, citing substantial direct and indirect healthcare costs attributable to medication-related harm. Epidemiological data further underscore the frequency of readmissions and emergency visits linked to suboptimal medication processes during transitions, highlighting the urgency of system-level interventions.

Pathophysiology

The pathophysiology of medication-related harm in care transitions is multifactorial. Disruption in medication continuity, lack of comprehensive medication reconciliation, and inadequate monitoring can precipitate pharmacokinetic and pharmacodynamic imbalances. For instance, abrupt cessation or duplication of antihypertensives, anticoagulants, or antidiabetic agents can result in acute clinical decompensation or toxicity. Variability in organ function, altered drug metabolism, and drug–drug interactions compound the risk, particularly in older adults or those with renal or hepatic impairment. Mechanism-based understanding of these processes is essential for anticipating potential risks and implementing preventive strategies during transitions.

Risk Factors

Several risk factors heighten the likelihood of medication errors during transitions. These include polypharmacy (use of ≥5 medications), communication breakdowns between healthcare teams, incomplete or inaccurate documentation, cognitive impairment, low health literacy, and the absence of standardized reconciliation protocols. Patients transitioning from hospital to home or long-term care facilities are at increased risk due to changes in prescribing authority, formulary restrictions, and limited access to outpatient follow-up. Socioeconomic barriers and language differences may further impede safe medication management, necessitating tailored interventions for high-risk groups.

Clinical Features

Clinically, medication-related problems during transitions may manifest as unexplained clinical deterioration, new or worsening symptoms, therapeutic failure, or overt toxicity. Signs and symptoms often depend on the medication class involved; for example, hypoglycemia from insulin errors, bleeding from anticoagulant mismanagement, or hypertensive crises from missed antihypertensives. Subtle presentations, such as confusion, falls, or gastrointestinal disturbances, may also signal underlying medication discrepancies. Prompt recognition and attribution of these features to medication transitions are vital for timely intervention and prevention of further harm.

Diagnosis

Diagnosing medication-related issues during care transitions requires a systematic approach, incorporating comprehensive medication reconciliation, patient interviews, and review of previous medical records. Best practices involve verification of all prescribed, over-the-counter, and complementary medications, as well as assessment of adherence and understanding. Electronic health records (EHRs) and clinical decision support systems can aid in identifying potential drug interactions or duplications. Interdisciplinary medication review, involving pharmacists, nurses, and physicians, is critical for accurate diagnosis and resolution of discrepancies.

Treatment & Management

Effective management hinges on a structured medication reconciliation process at every transition point. Interventions include pre-discharge medication counseling, clear discharge summaries, and post-discharge follow-up (e.g., "medication reconciliation within 72 hours"). Clinical pharmacists play a pivotal role in reviewing complex regimens, educating patients and caregivers, and facilitating communication between hospital and community providers. Case-based learning modules have demonstrated efficacy in equipping clinicians with the skills necessary to identify potential medication risks and implement corrective actions. Individualized care plans and use of technology (e.g., e-prescribing, telemedicine) further enhance medication safety.

Recent Advances / Emerging Therapies

Recent advances include the integration of artificial intelligence (AI) and machine learning algorithms into EHRs to flag high-risk medication profiles and automate reconciliation. Mobile health applications now enable real-time medication tracking and adherence support post-discharge. Interprofessional education initiatives, utilizing simulated case scenarios, have improved provider competency in medication management across transitions. Emerging therapies, such as long-acting formulations, fixed-dose combinations, and pharmacogenomic-guided prescribing, are being explored to streamline regimens and reduce transition-related risks, especially in populations with complex needs.

Guideline Recommendations

International and national guidelines, including those from the Institute for Healthcare Improvement (IHI) and the Joint Commission, advocate for standardized medication reconciliation at all transition points. Key recommendations encompass clear documentation of medication changes, patient and caregiver education, and the use of multidisciplinary teams. The American Society of Health-System Pharmacists (ASHP) and National Institute for Health and Care Excellence (NICE) further emphasize the role of clinical pharmacists and tailored interventions for high-risk patients. Adherence to these guidelines, supported by case-based training, is associated with reduced ADEs and improved patient outcomes.

Conclusion

Medication optimization during care transitions remains a cornerstone of patient safety and high-quality healthcare delivery. Case-based learning serves as a powerful modality to translate evidence-based principles into clinical practice, fostering critical thinking and collaborative problem-solving among healthcare professionals. By embracing guideline-directed strategies, leveraging technological innovations, and prioritizing individualized care, clinicians can significantly reduce medication errors and enhance therapeutic outcomes during vulnerable transition periods. Ongoing research and continuous education are imperative to sustain progress in this evolving field.